Metabolic associated fatty liver disease increases risk of adverse events after acute coronary syndrome

被引：0
|
作者：
Chew, N. [1 ]
Ng, C. H. [2 ]
Kong, G. [2 ]
Chin, Y. H. [2 ]
Lim, O. [3 ]
Lim, W. H. [3 ]
Dalakoti, M. [3 ]
Khoo, C. M. [2 ]
Kong, W. [1 ]
Poh, K. K. [1 ]
Foo, R. [1 ]
Lee, C. H. [1 ]
Chan, M. Y. [1 ]
Muthiah, M. [2 ]
Loh, P. H. [1 ]
机构：
[1] Natl Univ Heart Ctr, Singapore, Singapore
[2] Natl Univ Hlth Syst, Singapore, Singapore
[3] Natl Univ Singapore, Singapore, Singapore
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1414 / 1414
页数：1
相关论文
共 50 条
  • [1] Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome
    Cavallari, Ilaria
    Cannon, Christopher P.
    Braunwald, Eugene
    Goodrich, Erica L.
    Im, KyungAh
    Lukas, Mary Ann
    O'Donoghue, Michelle L.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (08) : 830 - 838
  • [2] Adverse events associated with stopping clopidogrel after acute coronary syndrome
    Goyal, Sandeep K.
    Punnam, Sujeeth R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (20): : 2389 - 2389
  • [3] Risk scores in predicting adverse events after an acute coronary syndrome
    Duarte, F.
    Barradas, M., I
    Oliveira, L.
    Serena, C.
    Fontes, A.
    Monteiro, A.
    Machado, C.
    Dourado, R.
    Santos, E.
    Pelicano, N.
    Pacheco, M.
    Tavares, A.
    Martins, D.
    EUROPEAN HEART JOURNAL, 2022, 43
  • [4] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [5] Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
    Hui-Hui Liu
    Ye-Xuan Cao
    Jing-Lu Jin
    Yuan-Lin Guo
    Cheng-Gang Zhu
    Na-Qiong Wu
    Ying Gao
    Rui-Xia Xu
    Qian Dong
    Ming-Hua Zheng
    Jian-Jun Li
    Hepatology International, 2021, 15 : 1337 - 1346
  • [6] Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study
    Liu, Hui-Hui
    Cao, Ye-Xuan
    Jin, Jing-Lu
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Gao, Ying
    Xu, Rui-Xia
    Dong, Qian
    Zheng, Ming-Hua
    Li, Jian-Jun
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1337 - 1346
  • [7] Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B
    van Kleef, Laurens A.
    Choi, Hannah S. J.
    Brouwer, Willem P.
    Hansen, Bettina E.
    Patel, Keyur
    de Man, Robert A.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    Sonneveld, Milan J.
    JHEP REPORTS, 2021, 3 (05)
  • [8] Adverse events associated with high clopidogrel loading doses after acute coronary syndrome
    Pizzi, C.
    Dorobantu, M.
    Tatu-Chitoiu, G.
    Calmac, L.
    Manfrini, O.
    Udeanu, M.
    Craiu, E.
    Macarie, C.
    Bugiardini, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 328 - 328
  • [9] Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
    Okkonen, Marjo
    Havulinna, Aki S.
    Ukkola, Olavi
    Huikuri, Heikki
    Pietila, Arto
    Koukkunen, Heli
    Lehto, Seppo
    Mustonen, Juha
    Ketonen, Matti
    Airaksinen, Juhani
    Kesaniemi, Y. Antero
    Salomaa, Veikko
    ANNALS OF MEDICINE, 2021, 53 (01) : 817 - 823
  • [10] METABOLIC SYNDROME AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME: INSIGHTS FROM SOLID-TIMI 52 TRIAL
    Cavallari, Ilaria
    Cannon, Christopher
    Braunwald, Eugene
    Goodrich, Erica
    Im, Kyungah
    Lukas, Mary Ann
    O'Donoghue, Michelle
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 448 - 448
12345